撒哈拉以南非洲地区COVID-19危重患者急性肾损伤的患病率、相关因素和预后:一项回顾性单中心研究

IF 1.1 4区 医学 Q3 UROLOGY & NEPHROLOGY
Mansour Mbengue, Abdelhakh Achafi, Ibrahima Gaye, Jatt Tshabayembi, Fatou Ndiaye, Cheikh M F Kitane, Abdou Niang
{"title":"撒哈拉以南非洲地区COVID-19危重患者急性肾损伤的患病率、相关因素和预后:一项回顾性单中心研究","authors":"Mansour Mbengue, Abdelhakh Achafi, Ibrahima Gaye, Jatt Tshabayembi, Fatou Ndiaye, Cheikh M F Kitane, Abdou Niang","doi":"10.5414/CN111607","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Acute kidney injury (AKI) constitutes a complication frequently encountered in patients with severe forms of COVID-19. The aim of this study was to evaluate the prevalence of acute kidney injury and to describe its associated factors.</p><p><strong>Materials and methods: </strong>This was a retrospective, descriptive, analytical study over a period of 18 months at Dalal Jamm Hospital in Dakar. We included all patients admitted to the intensive care unit for the treatment of COVID-19. AKI was defined according to KDIGO 2012.</p><p><strong>Results: </strong>During the study period, we collected 170 files. The mean age was 59.38 ± 14.81 years, and 40.6% were women. Hypertension and diabetes mellitus were the most frequently found comorbidities, respectively, in 37.65% and 31.18% of cases. AKI was present in 50 (29.4%) patients. Acute tubular injury was found in 44% of cases. Hemodialysis was performed in 10% of cases, and the indications were hyperkalemia (100%), and uremic encephalopathy (40%). Death occurred in 62.36% of cases. Recovery of renal function during hospitalization was noted in 16% of patients. In multivariable analysis, the factors associated with AKI were obesity (p = 0.020; adjusted odds ratio (aOR) = 7.406; 95% CI = 2.25 - 37.11) and non-renal Sequential Organ Failure Assessment (SOFA) (p = 0.001; aOR = 5.851; 95% CI = 3.04 - 11.2). AKI was an independently associated factor with death (p = 0.002; aOR = 4.510; 95% CI = 2.51 - 9.52).</p><p><strong>Conclusion: </strong>AKI is common during COVID-19. AKI is correlated with the severity of the disease and the presence of comorbidities. AKI is independently associated with increased risk of death in COVID-19.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence, associated factors, and prognosis of acute kidney injury in critically ill patients with COVID-19 in sub-Saharan Africa: A retrospective single-center study.\",\"authors\":\"Mansour Mbengue, Abdelhakh Achafi, Ibrahima Gaye, Jatt Tshabayembi, Fatou Ndiaye, Cheikh M F Kitane, Abdou Niang\",\"doi\":\"10.5414/CN111607\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Acute kidney injury (AKI) constitutes a complication frequently encountered in patients with severe forms of COVID-19. The aim of this study was to evaluate the prevalence of acute kidney injury and to describe its associated factors.</p><p><strong>Materials and methods: </strong>This was a retrospective, descriptive, analytical study over a period of 18 months at Dalal Jamm Hospital in Dakar. We included all patients admitted to the intensive care unit for the treatment of COVID-19. AKI was defined according to KDIGO 2012.</p><p><strong>Results: </strong>During the study period, we collected 170 files. The mean age was 59.38 ± 14.81 years, and 40.6% were women. Hypertension and diabetes mellitus were the most frequently found comorbidities, respectively, in 37.65% and 31.18% of cases. AKI was present in 50 (29.4%) patients. Acute tubular injury was found in 44% of cases. Hemodialysis was performed in 10% of cases, and the indications were hyperkalemia (100%), and uremic encephalopathy (40%). Death occurred in 62.36% of cases. Recovery of renal function during hospitalization was noted in 16% of patients. In multivariable analysis, the factors associated with AKI were obesity (p = 0.020; adjusted odds ratio (aOR) = 7.406; 95% CI = 2.25 - 37.11) and non-renal Sequential Organ Failure Assessment (SOFA) (p = 0.001; aOR = 5.851; 95% CI = 3.04 - 11.2). AKI was an independently associated factor with death (p = 0.002; aOR = 4.510; 95% CI = 2.51 - 9.52).</p><p><strong>Conclusion: </strong>AKI is common during COVID-19. AKI is correlated with the severity of the disease and the presence of comorbidities. AKI is independently associated with increased risk of death in COVID-19.</p>\",\"PeriodicalId\":10396,\"journal\":{\"name\":\"Clinical nephrology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2025-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical nephrology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5414/CN111607\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5414/CN111607","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

急性肾损伤(AKI)是重症COVID-19患者经常遇到的并发症。本研究的目的是评估急性肾损伤的患病率,并描述其相关因素。材料和方法:这是一项在达喀尔Dalal Jamm医院进行的为期18个月的回顾性、描述性和分析性研究。我们纳入了重症监护病房治疗COVID-19的所有患者。AKI是根据KDIGO 2012定义的。结果:在研究期间,我们收集了170份文件。平均年龄59.38±14.81岁,女性占40.6%。高血压和糖尿病是最常见的合并症,分别占37.65%和31.18%。50例(29.4%)患者存在AKI。急性肾小管损伤发生率为44%。10%的病例进行了血液透析,适应症为高钾血症(100%)和尿毒症脑病(40%)。62.36%的病例死亡。16%的患者在住院期间肾功能恢复。在多变量分析中,与AKI相关的因素是肥胖(p = 0.020;调整优势比(aOR) = 7.406;95% CI = 2.25 - 37.11)和非肾序贯器官衰竭评估(SOFA) (p = 0.001;aOR = 5.851;95% ci = 3.04 - 11.2)。AKI是死亡的独立相关因素(p = 0.002;aOR = 4.510;95% ci = 2.51 - 9.52)。结论:AKI在COVID-19患者中很常见。AKI与疾病的严重程度和合并症的存在相关。AKI与COVID-19死亡风险增加独立相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Prevalence, associated factors, and prognosis of acute kidney injury in critically ill patients with COVID-19 in sub-Saharan Africa: A retrospective single-center study.

Introduction: Acute kidney injury (AKI) constitutes a complication frequently encountered in patients with severe forms of COVID-19. The aim of this study was to evaluate the prevalence of acute kidney injury and to describe its associated factors.

Materials and methods: This was a retrospective, descriptive, analytical study over a period of 18 months at Dalal Jamm Hospital in Dakar. We included all patients admitted to the intensive care unit for the treatment of COVID-19. AKI was defined according to KDIGO 2012.

Results: During the study period, we collected 170 files. The mean age was 59.38 ± 14.81 years, and 40.6% were women. Hypertension and diabetes mellitus were the most frequently found comorbidities, respectively, in 37.65% and 31.18% of cases. AKI was present in 50 (29.4%) patients. Acute tubular injury was found in 44% of cases. Hemodialysis was performed in 10% of cases, and the indications were hyperkalemia (100%), and uremic encephalopathy (40%). Death occurred in 62.36% of cases. Recovery of renal function during hospitalization was noted in 16% of patients. In multivariable analysis, the factors associated with AKI were obesity (p = 0.020; adjusted odds ratio (aOR) = 7.406; 95% CI = 2.25 - 37.11) and non-renal Sequential Organ Failure Assessment (SOFA) (p = 0.001; aOR = 5.851; 95% CI = 3.04 - 11.2). AKI was an independently associated factor with death (p = 0.002; aOR = 4.510; 95% CI = 2.51 - 9.52).

Conclusion: AKI is common during COVID-19. AKI is correlated with the severity of the disease and the presence of comorbidities. AKI is independently associated with increased risk of death in COVID-19.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical nephrology
Clinical nephrology 医学-泌尿学与肾脏学
CiteScore
2.10
自引率
9.10%
发文量
138
审稿时长
4-8 weeks
期刊介绍: Clinical Nephrology appears monthly and publishes manuscripts containing original material with emphasis on the following topics: prophylaxis, pathophysiology, immunology, diagnosis, therapy, experimental approaches and dialysis and transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信